Catheter Precision (VTAK) Short term Debt (2025 - 2026)
Catheter Precision's (VTAK) quarterly Short term Debt came in at $6.5 million in Q1 2026, up 2094.63% quarter-over-quarter from $298000.0 in Q4 2025.
Powered by 
Analysis
Catheter Precision (VTAK) Short term Debt (2025 - 2026) Analysis & Trends
Catheter Precision (VTAK) has reported Short term Debt for 2 consecutive years, with $6.5 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $298000.0, changed N/A from the prior year.
- Short term Debt was $6.5 million for Q1 2026 at Catheter Precision, up from $298000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $6.5 million in Q1 2026 and troughed at $298000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Catheter Precision | 480,427.59 | -1.36 Mn | 98,000.00 |